Vaccination-associated anaphylaxis in adults: diagnostic testing ruling out IgE-mediated vaccine allergy (Q39981105)

16 September 2017

title

Vaccination-associated anaphylaxis in adults: diagnostic testing ruling out IgE-mediated vaccine allergy (English)

1 reference

16 September 2017

1 reference

1 reference

2

Eva-B Bröcker

1 reference

16 September 2017

Cornelia S Seitz

1

1 reference

16 September 2017

Axel Trautmann

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

25 April 2009

1 reference

16 September 2017

1 reference

16 September 2017

volume

27

1 reference

16 September 2017

issue

29

1 reference

16 September 2017

page(s)

3885-3889

1 reference

Mechanisms underlying adverse reactions to vaccines

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Vaccine allergy: diagnosis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Update on side effects from common vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Risk assessment in anaphylaxis: current and future approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Clinical features and severity grading of anaphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

A practical approach to immunization in atopic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Risk of Anaphylaxis After Vaccination of Children and Adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

The safety of egg-containing vaccines for egg-allergic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Safe administration of influenza vaccine to patients with egg allergy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Current issues with influenza vaccination in egg allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Change in gelatin content of vaccines associated with reduction in reports of allergic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Dermal testing of vaccines for children at high risk of allergies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Anaphylaxis: a review of causes and mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Nonspecific medication side effects and the nocebo phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

The placebo: from specificity to the non-specific and back.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Scientific and ethical issues in the use of placebo controls in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Functional somatic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Latex allergy. A position paper of the British Society of Allergy and Clinical Immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

Mastocytosis and allergy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2009.04.020

10.1016/J.VACCINE.2009.04.020

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference